These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 879288

  • 21. Inhibitory effects of nisoldipine and saralasin on angiotensin II-induced antidiuresis in anesthetized dogs.
    Kageyama M, Matsumura Y, Hayashi K, Hosokawa T, Morimoto S.
    Jpn J Pharmacol; 1990 Feb; 52(2):245-53. PubMed ID: 2313933
    [Abstract] [Full Text] [Related]

  • 22. The renin-angiotensin-aldosterone system in patients with nephrotic syndrome: effects of 1-sar-8-ala-angiotensin II.
    Düsing R, Vetter H, Kramer HJ.
    Nephron; 1980 Feb; 25(4):187-92. PubMed ID: 6990285
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Effects of prostaglandins E 1 , A 1 , and F 2 on renal handling of salt and water.
    Gross JB, Barter FC.
    Am J Physiol; 1973 Jul; 225(1):218-24. PubMed ID: 4351670
    [No Abstract] [Full Text] [Related]

  • 25. Effects of prolonged administration of vasopressin on plasma sodium and on renal excretion of electrolytes and water.
    Chan WY.
    J Pharmacol Exp Ther; 1971 Jul; 178(1):141-51. PubMed ID: 5087392
    [No Abstract] [Full Text] [Related]

  • 26. Effects of angiotensin II and 1-Sar-8-Ala-angiotensin II on the renal function in sodium-replete and -deplete dogs [proceedings].
    Lijnen PJ, Fagard RH, Amery AK.
    Arch Int Physiol Biochim; 1979 Feb; 87(1):193-4. PubMed ID: 92269
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Overview of the role of angiotensin inhibitors in delineating the function of the renin-angiotensin system.
    McCaa RE.
    Prog Biochem Pharmacol; 1980 Feb; 17():29-35. PubMed ID: 7010367
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Possibility that angiotensin resulting from unilateral kidney disease affects contralateral renal function.
    Fourcade JC, Navar LG, Guyton AC.
    Nephron; 1971 Feb; 8(1):1-16. PubMed ID: 4345501
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [The significance of the dose and hypertension in realizing the renal effect of angiotensin].
    Branchevskiĭ LL.
    Biull Eksp Biol Med; 1973 May; 75(5):53-5. PubMed ID: 4360361
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Effect of saralasin infusion on glomerular filtration rate and sodium excretion in hypertensive patients (author's transl)].
    de Franca Borges H, da Silva Saragoça MA, Kater CE, Ribeiro AB, Ajzen H, Ramos OL.
    Rev Bras Pesqui Med Biol; 1979 Sep; 12(4-5):293-302. PubMed ID: 531273
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.